Vireo Growth (VREOF) Cash & Equivalents (2020 - 2026)

Vireo Growth (VREOF) reported Cash & Equivalents of $137.8 million for Q1 2026, up 59.86% on a YoY basis from $86.2 million in Q1 2025, and up 12.49% sequentially from $122.5 million in Q4 2025.

Vireo Growth (VREOF) Cash & Equivalents (2020 - 2026) Analysis & Trends

Vireo Growth (VREOF) has 7 years of Cash & Equivalents data on file, last reported at $137.8 million in Q1 2026.

  • For the quarter ending Q1 2026, Cash & Equivalents rose 59.86% year-over-year to $137.8 million; the trailing twelve-month figure through Mar 2026 stood at $137.8 million (up 59.86% YoY), and the FY2025 full-year result was $122.5 million, up 33.73% from the prior year.
  • Cash & Equivalents advanced to $137.8 million in Q1 2026, from $122.5 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $137.8 million in Q1 2026 to a low of $7.3 million in Q3 2024.
  • A 5-year average of $47.0 million and a median of $16.0 million in 2023 frame the typical range for Cash & Equivalents.
  • Across the five-year window, Cash & Equivalents tumbled 78.79% in 2022 and surged 1514.58% in 2025, its largest moves.
  • Tracing VREOF's Cash & Equivalents over 5 years: stood at $15.1 million in 2022, then rose by 5.38% to $16.0 million in 2023, then soared by 473.77% to $91.6 million in 2024, then soared by 33.73% to $122.5 million in 2025, then increased by 12.49% to $137.8 million in 2026.
  • Business Quant data shows VREOF's Cash & Equivalents at $137.8 million in Q1 2026, $122.5 million in Q4 2025, and $117.5 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 1.76 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 3.74 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 1.94 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 3.79 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 1.28 Bn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 33.59 Bn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 1.80 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 266.50 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 428.00 Mn
10 Vireo Growth 10.57 Bn 10.41 Bn 59.30 Mn 137.80 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 137.80 Mn
Dec 31, 2025 122.50 Mn
Sep 30, 2025 117.54 Mn
Jun 30, 2025 99.13 Mn
Mar 31, 2025 86.20 Mn
Dec 31, 2024 91.60 Mn
Sep 30, 2024 7.28 Mn
Jun 30, 2024 11.23 Mn
Mar 31, 2024 12.60 Mn
Dec 31, 2023 15.96 Mn
Sep 30, 2023 13.30 Mn
Jun 30, 2023 11.35 Mn
Mar 31, 2023 10.35 Mn
Dec 31, 2022 15.15 Mn
Sep 30, 2022 21.84 Mn
Jun 30, 2022 16.97 Mn
Mar 31, 2022 8.60 Mn
Dec 31, 2021 15.16 Mn
Sep 30, 2021 11.78 Mn
Jun 30, 2021 20.83 Mn